{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:47:34Z","timestamp":1775245654364,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T00:00:00Z","timestamp":1485993600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["#474397\/2013-0"],"award-info":[{"award-number":["#474397\/2013-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s12640-016-9691-8","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T01:08:16Z","timestamp":1485997696000},"page":"464-477","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Intracerebroventricular Administration of Streptozotocin as an Experimental Approach to Depression: Evidence for the Involvement of Proinflammatory Cytokines and Indoleamine-2,3-Dioxygenase"],"prefix":"10.1007","volume":"31","author":[{"given":"Leandro Cattelan","family":"Souza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano R.","family":"Jesse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo Gomes","family":"de Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristini Escobar","family":"Viana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etiara","family":"Mattos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neici C\u00e1ceres","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana Peterini","family":"Boeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,2]]},"reference":[{"key":"9691_CR1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1503\/jpn.110071","volume":"36","author":"H Anisman","year":"2011","unstructured":"Anisman H (2011) Inflaming depression. J Psychiatry Neurosci 36:291\u2013295","journal-title":"J Psychiatry Neurosci"},{"key":"9691_CR2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/archgenpsychiatry.2007.11","volume":"65","author":"DA Barton","year":"2008","unstructured":"Barton DA, Esler MD, Dawood T, Lambert EA, Haikerwal D, Brenchley C, Socratous F, Hastings J, Guo L, Wiesner G, Kaye DM, Bayles R, Schlaich MP, Lambert GW (2008) Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy. Arch Gen Psychiatry 65:38\u201346","journal-title":"Arch Gen Psychiatry"},{"key":"9691_CR3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal Biochem 72:248\u2013254","journal-title":"Anal Biochem"},{"key":"9691_CR4","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1200\/JCO.2000.18.10.2143","volume":"18","author":"L Capuron","year":"2000","unstructured":"Capuron L, Ravaud A, Dantzer R (2000) Early depressive symptoms in cancer patients receiving interleukin 2 and\/or interferon alfa-2b therapy. J Clin Oncol 18:2143\u20132151","journal-title":"J Clin Oncol"},{"key":"9691_CR5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0306-4530(01)00030-0","volume":"26","author":"L Capuron","year":"2001","unstructured":"Capuron L, Ravaud A, Gualde N, Bosmans E, Dantzer R, Maes M, Neveu PJ (2001) Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 26:797\u2013808","journal-title":"Psychoneuroendocrinology"},{"key":"9691_CR6","first-page":"431","volume":"7","author":"DM Christmas","year":"2011","unstructured":"Christmas DM, Potokar J, Davies SJ (2011) A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase. Neuropsychiatric Dis Treat 7:431\u2013439","journal-title":"Neuropsychiatric Dis Treat"},{"key":"9691_CR7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bbi.2012.08.008","volume":"31","author":"AW Corona","year":"2013","unstructured":"Corona AW, Norden DM, Skendelas JP, Huang Y, O'Connor JC, Lawson M, Dantzer R, Kelley KW, Godbout JP (2013) Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX(3)CR1)-deficient mice. Brain Behav Immun 31:134\u2013142","journal-title":"Brain Behav Immun"},{"key":"9691_CR8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1099-1077(200003)15:2<113::AID-HUP150>3.0.CO;2-W","volume":"15","author":"JF Cryan","year":"2000","unstructured":"Cryan JF, Leonard BE (2000) 5-HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response. Hum Psychopharmacol 15:113\u2013135","journal-title":"Hum Psychopharmacol"},{"key":"9691_CR9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","volume":"23","author":"JF Cryan","year":"2002","unstructured":"Cryan JF, Markou A, Lucki I (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23:238\u2013245","journal-title":"Trends Pharmacol Sci"},{"key":"9691_CR10","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.1007\/s12035-015-9617-0","volume":"53","author":"IC Da Silva Dias","year":"2016","unstructured":"Da Silva Dias IC, Carabelli B, Ishii DK, de Morais H, de Carvalho MC, Rizzo de Souza LE, Zanata SM, Brand\u00e3o ML, Cunha TM, Ferraz AC, Cunha JM, Zanoveli JM (2016) Indoleamine-2,3-dioxygenase\/kynurenine pathway as a potential pharmacological target to treat depression associated with diabetes. Mol Neurobiol 53:6997\u20137009","journal-title":"Mol Neurobiol"},{"key":"9691_CR11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46\u201356","journal-title":"Nat Rev Neurosci"},{"key":"9691_CR12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.psyneuen.2010.09.012","volume":"36","author":"R Dantzer","year":"2011","unstructured":"Dantzer R, O\u2019Connor JC, Lawson MA, Kelley KW (2011) Inflammation associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 36:426\u2013436","journal-title":"Psychoneuroendocrinology"},{"key":"9691_CR13","first-page":"775","volume":"43","author":"LL Du","year":"2015","unstructured":"Du LL, Chai DM, Zhao LN, Li XH, Zhang FC, Zhang HB, Liu LB, Wu K, Liu R, Wang JZ, Zhou XW (2015) AMPK activation ameliorates Alzheimer's disease-like pathology and spatial memory impairment in a streptozotocin-induced Alzheimer's disease model in rats. J Alzheimers Dis 43:775\u2013784","journal-title":"J Alzheimers Dis"},{"key":"9691_CR14","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/j.1471-4159.1991.tb06359.x","volume":"57","author":"AJ Dunn","year":"1991","unstructured":"Dunn AJ, Welch J (1991) Stress- and endotoxin-induced increases in brain tryptophan and serotonin metabolism depend on sympathetic nervous system activity. J Neurochem 57:1615\u20131622","journal-title":"J Neurochem"},{"key":"9691_CR15","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0091-3057(02)00750-5","volume":"72","author":"AC Ferraz","year":"2002","unstructured":"Ferraz AC, Anselmo-Franci JA, Perosa SR, de Castro-Neto EF, Bellissimo MI, de Oliveira BH, Cavalheiro EA, Naffah-Mazzacoratti Mda G, Da Cunha C (2002) Aminoacid and monoamine alterations in the cerebral cortex and hippocampus of mice submitted to ricinine-induced seizures. Pharmacol Biochem Behav 72:779\u2013786","journal-title":"Pharmacol Biochem Behav"},{"key":"9691_CR16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/jb\/mvj072","volume":"139","author":"H Fujigaki","year":"2006","unstructured":"Fujigaki H, Saito K, Fujigaki S, Takemura M, Sudo K, Ishiguro H, Seishima M (2006) The signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 are not essential for the induction of indoleamine 2,3-dioxygenase by lipopolysaccharide: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways, and synergistic effect of several proinflammatory cytokines. J Biochem (Tokyo) 139:655\u2013662","journal-title":"J Biochem (Tokyo)"},{"key":"9691_CR17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bbi.2012.11.010","volume":"28","author":"SM Gibney","year":"2013","unstructured":"Gibney SM, McGuinness B, Prendergast C, Harkin A, Connor TJ (2013) Poly I:C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression. Brain Behav Immun 28:170\u2013181","journal-title":"Brain Behav Immun"},{"key":"9691_CR18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuroscience.2013.09.042","volume":"256","author":"AT Goes","year":"2014","unstructured":"Goes AT, Souza LC, Filho CB, Del Fabbro L, De Gomes MG, Boeira SP, Jesse CR (2014) Neuroprotective effects of swimming training in a mouse model of Parkinson's disease induced by 6-hydroxydopamine. Neuroscience 256:61\u201371","journal-title":"Neuroscience"},{"key":"9691_CR19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/npp.2011.205","volume":"37","author":"E Haroon","year":"2012","unstructured":"Haroon E, Raison CL, Miller AH (2012) Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 37:137\u2013162","journal-title":"Neuropsychopharmacology"},{"key":"9691_CR20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pbb.2006.12.003","volume":"86","author":"S Hirano","year":"2007","unstructured":"Hirano S, Miyata S, Kamei J (2007) Antidepressant-like effect of leptin in streptozotocin-induced diabetic mice. Pharmacol Biochem Behav 86:27\u201331","journal-title":"Pharmacol Biochem Behav"},{"key":"9691_CR21","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.physbeh.2011.09.003","volume":"105","author":"N Ho","year":"2012","unstructured":"Ho N, Balu DT, Hilario MR, Blendy JA, Lucki I (2012) Depressive phenotypes evoked by experimental diabetes are reversed by insulin. Physiol Behav 105:702\u2013708","journal-title":"Physiol Behav"},{"key":"9691_CR22","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3109\/00207454.2014.890934","volume":"124","author":"K Kalafatakis","year":"2014","unstructured":"Kalafatakis K, Zarros A (2014) Intracerebroventricular administration of streptozotocin as an experimental approach to Alzheimer's disease. Int J Neurosci 124:944\u2013946","journal-title":"Int J Neurosci"},{"key":"9691_CR23","first-page":"10","volume":"18","author":"MA Lawson","year":"2013","unstructured":"Lawson MA, Parrott JM, McCusker RH, Dantzer R, Kelley KW, O'Connor JC (2013) Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors. J Neuroinflammation 18:10\u201387","journal-title":"J Neuroinflammation"},{"key":"9691_CR24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-6606-3-8","volume":"3","author":"S Lee","year":"2010","unstructured":"Lee S, Jeong J, Kwak Y, Park SK (2010) Depression research: where are we now? Molecular Brain 3:8","journal-title":"Molecular Brain"},{"key":"9691_CR25","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0889-1591(02)00014-4","volume":"16","author":"J Lestage","year":"2002","unstructured":"Lestage J, Verrier D, Palin K, Dantzer R (2002) The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain Behav Immun 16:596\u2013601","journal-title":"Brain Behav Immun"},{"key":"9691_CR26","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","volume":"35","author":"M Maes","year":"2011","unstructured":"Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R (2011) The new \u20185-HT\u2019 hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuro-Psychopharmacol Biol Psychiatry 35:702\u2013721","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"9691_CR27","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","volume":"3","author":"CD Mathers","year":"2006","unstructured":"Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3:e442","journal-title":"PLoS Med"},{"key":"9691_CR28","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65:732\u2013741","journal-title":"Biol Psychiatry"},{"key":"9691_CR29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0306-9877(03)00207-X","volume":"61","author":"AM Myint","year":"2003","unstructured":"Myint AM, Kim YK (2003) Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses 61:519\u2013525","journal-title":"Med Hypotheses"},{"key":"9691_CR30","first-page":"99","volume":"37","author":"A Neumeister","year":"2003","unstructured":"Neumeister A (2003) Tryptophan depletion, serotonin, and depression: where do we stand. Psychopharmacol Bull 37:99\u2013115","journal-title":"Psychopharmacol Bull"},{"key":"9691_CR31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4002148","volume":"14","author":"JC O\u2019Connor","year":"2009","unstructured":"O\u2019Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N, Kelley KW, Dantzer R (2009) Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14:511\u2013522","journal-title":"Mol Psychiatry"},{"key":"9691_CR32","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bbi.2010.02.006","volume":"24","author":"TM Piser","year":"2010","unstructured":"Piser TM (2010) Linking the cytokine and neurocircuitry hypotheses of depression: a translational framework for discovery and development of novel anti-depressants. Brain Behav Immun 24:515\u2013524","journal-title":"Brain Behav Immun"},{"key":"9691_CR33","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","volume":"266","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730\u2013732","journal-title":"Nature"},{"key":"9691_CR34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","volume":"463","author":"L Prut","year":"2003","unstructured":"Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463:3\u201333","journal-title":"Eur J Pharmacol"},{"key":"9691_CR35","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","volume":"15","author":"CL Raison","year":"2010","unstructured":"Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G, Spivey JR, Saito K, Miller AH (2010) CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry 15:393\u2013403","journal-title":"Mol Psychiatry"},{"key":"9691_CR36","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0024-3205(01)01498-9","volume":"70","author":"ALS Rodrigues","year":"2002","unstructured":"Rodrigues ALS, Da Silva GL, Mateussi AS, Fernandes ES, Miguel OG, Yunes RA, Calixto JB, Santos AR (2002) Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus. Life Sci 70:1347\u20131358","journal-title":"Life Sci"},{"key":"9691_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2014.10.003","volume":"127","author":"PB Rosa","year":"2014","unstructured":"Rosa PB, Ribeiro CM, Bettio LE, Colla A, Lieberknecht V, Moretti M, Rodrigues AL (2014) Folic acid prevents depressive-like behavior induced by chronic corticosterone treatment in mice. Pharmacol Biochem Behav 127:1\u20136","journal-title":"Pharmacol Biochem Behav"},{"key":"9691_CR38","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.yhbeh.2012.03.010","volume":"62","author":"A Salazar","year":"2012","unstructured":"Salazar A, Gonzalez-Rivera BL, Redus L, Parrott JM, O'Connor JC (2012) Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge. Horm Behav 62:202\u2013209","journal-title":"Horm Behav"},{"key":"9691_CR39","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00702-011-0651-4","volume":"118","author":"M Salkovic-Petrisic","year":"2011","unstructured":"Salkovic-Petrisic M, Osmanovic-Barilar J, Br\u00fcckner MK, Hoyer S, Arendt T, Riederer P (2011) Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer's disease: a long-term follow up study. J Neural Transm 118:765\u2013772","journal-title":"J Neural Transm"},{"key":"9691_CR40","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bbr.2012.01.034","volume":"229","author":"AS Shingo","year":"2012","unstructured":"Shingo AS, Kanabayashi T, Murase T, Kito S (2012) Cognitive decline in STZ-3\u00a0V rats is largely due to dysfunctional insulin signalling through the dentate gyrus. Behav Brain Res 229:378\u2013383","journal-title":"Behav Brain Res"},{"key":"9691_CR41","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/IAI.70.2.859-868.2002","volume":"70","author":"NM Silva","year":"2002","unstructured":"Silva NM, Rodrigues CV, Santoro MM, Reis LF, Alvarez-Leite JI, Gazzinelli RT (2002) Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1. Infect Immun 70:859\u2013868","journal-title":"Infect Immun"},{"key":"9691_CR42","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0306-9877(91)90272-Z","volume":"35","author":"RS Smith","year":"1991","unstructured":"Smith RS (1991) The macrophage theory of depression. Med Hypotheses 35:298\u2013306","journal-title":"Med Hypotheses"},{"key":"9691_CR43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/FBP.0b013e32835efc2f","volume":"24","author":"LC Souza","year":"2013","unstructured":"Souza LC, Filho CB, Fabbro LD, de Gomes MG, Goes AT, Jesse CR (2013) Depressive-like behaviour induced by an intracerebroventricular injection of streptozotocin in mice: the protective effect of fluoxetine, antitumour necrosis factor-\u03b1 and thalidomide therapies. Behav Pharmacol 24:79\u201386","journal-title":"Behav Pharmacol"},{"key":"9691_CR44","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrd870","volume":"1","author":"TW Stone","year":"2002","unstructured":"Stone TW, Darlington L (2002) Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 1:609\u2013620","journal-title":"Nat Rev Drug Discov"},{"key":"9691_CR45","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/978-1-4615-4709-9_68","volume":"467","author":"O Takikawa","year":"1999","unstructured":"Takikawa O, Tagawa Y, Iwakura Y, Yoshida R, Truscott RJ (1999) Interferon-gamma-dependent\/independent expression of indoleamine 2,3-dioxygenase. Studies with interferon-gamma-knockout mice. Adv Exp Med Biol 467:553\u2013557","journal-title":"Adv Exp Med Biol"},{"key":"9691_CR46","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.pnpbp.2006.01.029","volume":"30","author":"CW Tsao","year":"2006","unstructured":"Tsao CW, Lin YS, Chen CC, Bai CH, SR W (2006) Cytokines and serotonin transporter in patients with major depression. Prog Neuro-Psychopharmacol Biol Psychiatry 30:899\u2013905","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"9691_CR47","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000087097","volume":"52","author":"P Willner","year":"2005","unstructured":"Willner P (2005) Chronic mild stress (CMS) revisited: consistency and behavioural\u2013neurobiological concordance in the effects of CMS. Neuropsychobiology 52:90\u2013110","journal-title":"Neuropsychobiology"},{"key":"9691_CR48","first-page":"11","volume":"4","author":"W Xie","year":"2014","unstructured":"Xie W, Cai L, Yu Y, Gao L, Xiao L, He Q, Ren Z, Liu Y (2014) Activation of brain indoleamine 2,3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy. J Neuroinflammation 4:11\u201341","journal-title":"J Neuroinflammation"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-016-9691-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-016-9691-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-016-9691-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T05:34:24Z","timestamp":1498368864000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-016-9691-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["9691"],"URL":"https:\/\/doi.org\/10.1007\/s12640-016-9691-8","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,2]]}}}